Welcome

Danaher Wins U.S. Antitrust Approval for GE Biopharma Deal

March 19, 2020, 10:27 PM

Federal Trade Commission approves $21.4 billion takeover of General Electric’s biopharmaceutical business after Danaher agreed to sell assets to Sartorius AG.

  • Danaher will divest assets related to 10 products used to manufacture biopharmaceutical drugs, FTC says
  • NOTE: Companies won EU antitrust approval in December

To contact the reporter on this story: David McLaughlin in Washington at dmclaughlin9@bloomberg.net

To contact the editors responsible for this story: Sara Forden at sforden@bloomberg.net; Laura Curtis

© 2020 Bloomberg L.P. All rights reserved. Used with permission.

To read the full article log in.

Learn more about a Bloomberg Law subscription.